GBA1 and Parkinson disease: Reduced activity of GCase through genetic or chemical means leads to an increase in EV release in both cellular and animal studies [22,23,24,25], suggesting that EV-mediated mechanisms may play a central role in the GBA1-PD pathogenesis.